Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Nayak Abhay U reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Abhay U. Nayak received a compensation-related grant of 214.6155 Phantom Stock Units on 2026-07-10 under the Zoetis Supplemental Savings Plan. These cash-settled units track Zoetis common stock plus cash-equivalent investments and increase his phantom stock balance to 4,700.5887 units.
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received a grant of 308.0457 phantom stock units on July 10, 2026 under the Zoetis Supplemental Savings Plan at a reference value of $26.2200 per unit. These cash-settled units track the value of Zoetis common stock plus a small cash-equivalent component, and Esch now holds 806.4312 phantom stock units in total, representing an interest tied to 106.8946 underlying shares of Zoetis common stock.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 237.6361 phantom stock units on July 10, 2026 at a reference value of $26.2200 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 6,273.3823 units, economically corresponding to 82.4619 phantom common stock equivalents.
These phantom stock units are settled in cash after her separation from service and may be reallocated among investment funds, with Zoetis able to limit transfer timing and frequency; their value is determined by Zoetis common stock performance plus a small cash-equivalent component.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Executive Vice President Julie Fuller received a grant of 314.6453 phantom stock units on July 10, 2026 under the Zoetis Supplemental Savings Plan. These units are cash-settled based on Zoetis common stock value and cash-equivalent investments, bringing her total phantom stock unit holdings to 2112.6819.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 314.6453 phantom stock units at $26.2200 per unit under the Zoetis Supplemental Savings Plan. These cash-settled units track Zoetis common stock plus cash-equivalent investments and increase her phantom stock unit balance to 30,946.8610.
Zoetis Inc. reported that Executive Vice President Ferran Astorga Jeannette acquired 45.3272 Phantom Stock Units on 2026-07-10 under the Zoetis Supplemental Savings Plan. These units relate to 15.7289 underlying shares of common stock and bring the total phantom stock unit balance to 2296.1569. The units are settled in cash after separation from service, and their value is tied to Zoetis common stock plus cash-equivalent investments, which typically represent around 5% of each unit’s value.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported a compensation-related award of 363.0526 phantom stock units under the Zoetis Supplemental Savings Plan on July 10, 2026, at a reference value of $26.2200 per unit. These units are settled in cash after separation from service and their value is tied to Zoetis common stock plus cash-equivalent investments, which typically represent around 5% of each unit’s value. Following this credit, Wetteny holds 10,155.3554 phantom stock units directly.
Zoetis Inc. Executive Vice President Abhay U. Nayak filed an amended initial ownership report reflecting holdings of 4,485.9732 Phantom Stock Units tied to Zoetis common stock. This total includes an additional 2,977.2003 units that had been inadvertently omitted earlier and are held in the Zoetis Supplemental Savings Plan, where they are settled in cash following separation from service.
Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Mark Stetter reported receiving a grant of 317.6216 phantom stock units tied to Zoetis common stock, based on a value of $78.71 per unit. These units reflect the deferral of his director cash retainer into the Zoetis stock fund and bring his total phantom stock unit balance to 534.0883. Each phantom stock unit is economically equivalent to one Zoetis common share but will be settled in cash after he separates from service, so this filing reflects non-employee director compensation rather than an open-market stock purchase or sale.
Zoetis Inc. Executive Vice President Abhay U. Nayak filed an initial ownership report as he again became a Section 16 officer on June 15, 2026. The filing shows no directly held shares of Zoetis common stock but discloses multiple equity-based awards and deferred units tied to the stock price.
He holds phantom stock units under the Zoetis Supplemental Savings Plan linked to 1,508.7729 underlying shares of common stock, which will be settled in cash after separation from service. The report also lists stock options granted under Zoetis equity plans, including 8,106 options with a stated exercise price of $0.00 per share and additional option grants over several years with exercise prices such as $162.07, $196.14, $156.64 and $129.13 per share.
In addition, Nayak is reported to hold restricted stock units (RSUs) that each represent a contingent right to receive one share of Zoetis common stock. These RSUs, including blocks such as 1,902.1798 and 1,122.8284 underlying shares, generally vest in one-third installments on the first, second and third anniversaries of their respective grant dates, subject to continued service and certain earlier-vesting provisions.